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Fetal Microchimerism Is Common in Normal and Diseased
Vulvar Skin
To the Editor:
Lichen sclerosus (LS) is a chronic lymphocyte-mediated
disease predominantly affecting middle-aged women. The
etiology is elusive but LS has been linked to autoimmune
diseases, mainly by presentation with concomitant classical
autoimmune diseases, such as autoimmune thyroiditis and
gastritis (Goolamali et al, 1974; Harrington et al, 1981;
Meyrick Thomas et al, 1988; Powell et al, 1999, 2000). Fetal
microchimerism, which is the transfer of fetal progenitor
cells into maternal circulation during pregnancy and
engraftment into maternal tissues, has been implicated in
the development of autoimmune diseases, especially
Hashimoto’s thyroiditis and systemic sclerosis (Bianchi
et al, 1997; Artlett et al, 1998; Nelson et al, 1998; Klintschar
et al, 2001). Significantly more Y-chromosomal DNA was
identified in diseased tissues and blood of patients with
systemic sclerosis than in control patients (Johnson et al,
2001; Nelson 2001, 2002). LS and systemic sclerosis share
some histological and clinical features; therefore, we were
interested if Y-chromosomal DNA could also be detected
in LS.
We investigated formalin-fixed, paraffin-embedded ar-
chival material of four patient groups: (1) 27 patients with LS
(average age 65 y); (2) 11 patients with LS-associated SCC,
(average age 66.7 y); (3) 18 patients without LS (15 patients
with SCC unrelated to LS and three patients with vulvar
Paget’s disease (average age 72.5 y)) and (4) vulvar tissues
without pathological findings from nine autopsies (average
age 73 y). All patients had at least one male child (range
1–6), among their off spring. One patient had a blood
transfusion, two had Hashimoto’s thyroiditis and one patient
was treated for thyrotoxicosis. A further control group
included diseased vulvar tissues from eight patients with-
out male children to account for tissue transfer during
processing. Patient consent was obtained from all patients
when interviewed for medical/obstetrical history.
For each tissue block, two separate PCR analyses were
performed. Sections of 40 mm were transferred to two test
tubes and DNA was extracted using the QIAamp tissue kit
(Qiagen, Hilden, Germany). PCR was performed for the SRY
locus using ATA AGT ATC GAC CTC GTC GGA AG (forward)
and GCA CTT CGC TGC AGA GTA CCG AAG (reverse) as
primers. Approx. 50 ng DNA were used in a 12.5 mL assay
containing 2 mL 10  PCR buffer, 75 nM of each primer, and
200 mM each dNTP and 0.5 U Dynazyme DNA polymerase
(Finzymes, Espoo, Finland). Cycling conditions were 941C,
1 min per 591C, 1 min per 721C, 1 min 30 s for 45 cycles
followed by 601C for 45 min and a 251C hold. The
amplificates were run on horizontal native polyacrylamide
gels and bands were visualized by silver staining (McKeown
et al, 2000). Negative controls included samples contain-
ing reagents only and DNA extracted from blood of a
nulliparous woman. Positive controls were DNA extracted
from blood of a healthy man and from formalin-fixed and
paraffin-embedded tissues of Hashimoto’s thyroiditis
(Klintschar et al, 2001). All laboratory work was carried out
by female investigators.
Among the LS-group, 11 of 27 women with LS (40%)
and 2 of 11 women with LS-associated SCC (18%) had
Y-chromosomal DNA in their biopsies. Three of 15 women
with vulvar SCC without LS (20%), all three women with
vulvar Paget’s disease (100%) and four of nine ‘‘normal’’
vulvar biopsies (44%) contained Y-chromosomal DNA
(Fig 1). All tissues from women without male offsprings were
free of Y-chromosomal DNA. Demonstration of Y-chromo-
somal DNA in concomitant (three patients) or successive
(two patients) biopsies was heterogeneous. Among patients
with SCC, the detection rate of Y-chromosomal DNA was
similar irrespective of the presence or absence of LS (18%
vs 20%). Normal vulvar tissues had the highest incidence of
Y-chromosomal DNA, followed by the LS-group.The me-
chanism of ‘‘fetal microchimerism’’ depends on cellular
traffic between mother and fetus during pregnancy and
persistence of these cells for decades in various organs
such as the spleen and skin (Johnson et al, 2001, Nelson
2001, 2002), and the thyroid gland (Klintschar et al, 2001;
Srivatsa et al, 2001). The detection of Y-chromosomal DNA
in about 40% of normal and LS-diseased vulvar skin is
slightly higher than the reported ‘‘normal’’ distribution of
fetal microchimerism of 30%–35% in blood and skin of
healthy normal multiparous women (Nelson 2001, 2002).
Contamination by transfer of tissue between paraffin blocks
was ruled out by including tissue blocks of women without
male children. The heterogeneous detection in concomi-
tant/successive biopsies may depend on sampling and
disease stage/activity at the time of biopsy. Extensive tissue
damage and secondary inflammation may have resulted in
loss of microchimeric cells as demonstrated in Hashimoto’s
thyroiditis (Srivatsa et al, 2001). Tissue destruction may
explain the low incidence of Y-chromosomal DNA in
invasive vulvar SCC, although a large number of cases of
LS were advanced with extensive secondary tissue dam-
age. It is unknown weather fetal microchimerism occurs at
higher frequency in early LS and it is even more difficult to
speculate how microchimerism may be involved in the
disease process of LS. For systemic sclerosis, it has beenAbbreviation: LS, lichen sclerosus; SCC, squamous cell carcinoma
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suggested that the presence of fetal cells alone in tissues
is not enough for initiation of the disease process, but
that they combine with environmental harm such as vinyl
chloride to cause disease.
In summary, Y-chromosomal DNA can be demonstrated
in LS, but also in normal vulvar tissue and other vulvar
diseases. The detection rate of Y-chromosomal DNA in
vulvar skin and LS was slightly higher than previously
reported for non-genital normal skin, but our data do not
indicate a role for microchimerism in the pathogenesis of
LS. It is important to realize that persistent fetal micro-
chimerism is a common phenomenon in normal healthy
women. Furthermore, it occurs with a slightly higher
incidence in genital skin than in extragenital skin.
Sigrid Regauer, Patrizia Schwaiger,w Bernadette Liegl and
Michael Klintscharw
Institute of Pathology, Karl-Franzens-University of Graz, Graz, Austria;
wDepartment of Legal Medicine, Martin-Luther-University of
Halle-Wittenberg, Halle/Saar, Germany
This project was supported in part by the ‘‘Austrian Cancer Aid/
Styria’’, project number 04/2001.
DOI: 10.1111/j.0022-202X.2004.22428.x
Manuscript received September 26, 2003; accepted for publication
October 9, 2003
Address correspondence to: Sigrid Regauer, MD, Institute of Pathol-
ogy, Medical University of Graz, Auenbruggerplatz 25, A-8036 Graz,
Austria. Email: sigrid.regauer@meduni-graz.at
References
Artlett C, Smith J, Jiminez S: Identification of fetal cells in skin lesions from
women with systemic sclerosis. N Engl J Med 338:1186–1191, 1998
Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP: PCR
quantification of fetal cells in maternal in blood in normal and aneuploid
pregnancies. Am J Hum Genet 6:822–829, 1997
Goolamali SK, Barnes EW, Irvine WJ, Shuster S: Organ specific antibodies in
patients with lichen sclerosus. Br Med J 4:78–79, 1974
Harrington CII, Dunsmore R: An investigation into the incidence of auto-immune
disorders in patients with lichen sclerosus and atrophicus. Br J Dermatol
104:563–566, 1981
Johnson KL, Nelson JL, Furst DE, Sweeney PAM, Roberts DJ, Zhen DK, Bianchi
DW: Fetal microchimerism in tissue from multiple sites in women with
systemic sclerosis. Arthritis Rheum 44:1848–1854, 2001
Klintschar M, Schwaiger P, Mannweiler S, Regauer S, Kleiber M: Evidence of fetal
microchimerism in Hashimoto’s thyroiditis. J Clin Endocrinol Metab
86:2494–2498, 2001
McKeown B, Stickley J, Riordan A: Gender assignment by PCR of the SRY gene:
An improvement on amelogenin. In: Sensabaugh GF, Lincoln PJ, Olaisen
B (eds). Progress in Forensic Genetics 8. New York: Elsevier, 2000; p 433–
438
Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM: Lichen sclerosus and
atrophicus and autoimmunity—A study of 350 women. Br J Dermatol
118:41–46, 1988
Nelson JL: Microchimerism: Expanding new horizon in human health or incidental
remnant of pregnancy? Lancet 358:2011–2012, 2001
Nelson JL: Pregnancy and microchimeris in autoimmune disease: Protector or
insurgent? Arthritis Rheum 46:291–297, 2002
Nelson JL, Furst DE, Maloney S, et al: Microchimerism and HLA-compatible
relationships of pregnancy in scleroderma. Lancet 351:559–562, 1998
Powell J, Wojnarowska F, Winsey S, Marren K, Welsh P: Lichen sclerosus
premenarche: Autoimmunity and immunogenetics. Br J Dermatol
142:481–484, 2000
Powell JJ, Wojnarowska F: Lichen sclerosus. Lancet 353:1777–1783, 1999
Srivatsa B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW:
Microchimerism of presumed fetal origin in thyroid specimens from
women: A case–control study. Lancet 358:2034–2038, 2001
Figure 1
PCR analysis for Y-chromosomal DNA. Lane 1: Reagents without
DNA. Lane 2: DNA extracted from blood of woman without children.
Lane 3: Hashimoto’s thyroiditis. Lane 4: Blood of a healthy man. Lane
5–9: DNA extracted from tissues of LS and SCC without detectable Y-
chromosomal DNA. Lane 10–14: Strong signals corresponding to Y-
chromosomal DNA extracted from four patients with LS and one patient
with SCC unassociated with LS. The arrow indicates the 93 bp Y-
specific fragment (SRY gene). The samples are flanked by a 123 bp size
marker (shortest fragment 123 bp with a 123 bp increment).
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